Will the administration capitalize on the Indo-Pacific Economic Framework to drive medical innovation?

In December 2022, the United States launched negotiations for the Indo-Pacific Economic Framework (IPEF) with thirteen countries throughout the Indo-Pacific region, including Australia, India, Indonesia, Japan and Korea. PhRMA hasencouraged the Biden Administration to negotiate a comprehensive and ambitious agreement, including in April 2022 public comments submitted to theU.S. Trade Representative (USTR) and theU.S. Department of Commerce (DOC). Such an agreement would include strong intellectual property (IP) protections and predictable and transparent market access, regulatory and other provisions that advance scientific research, incentivize invention and production of medicines, dismantle unfair trade barriers, and improve the ability of U.S. biopharmaceutical manufacturers to export medicines to reach patients throughout the Indo-Pacific region.
Source: The Catalyst - Category: Pharmaceuticals Authors: Tags: Intellectual Property Trade Source Type: news